Modified neuraminidase
Grant
US12577570B2
Kind: B2
Mar 17, 2026
Assignee
Tokushima University
Inventors
Kohji Itoh, Jun Tsukimoto
Abstract
Provided are a modified-type neuraminidase, a gene encoding the modified-type neuraminidase, a combination of the modified-type neuraminidase and cathepsin A, a combination of the gene encoding the modified-type neuraminidase and a gene encoding cathepsin A, a vector including said genes, and a pharmaceutical composition containing same. The pharmaceutical composition can be used for the therapy of lysosomal storage disease.
CPC Classifications
C12N 15/52
C12N 9/485
C12N 15/86
C12N 2750/14143
C12N 9/2402
C12N 2800/107
A61P 3/00
A61P 43/00
A01K 2217/075
A01K 2227/105
A01K 2267/0306
A61K 38/00
A61K 38/47
A61K 48/0008
A61K 48/005
C12Y 302/01018
C12Y 304/16005
Filing Date
2020-07-03
Application No.
17623302
Claims
20